Screening Dr Helen Raison Consultant, Public Health Royal Borough of Kingston What is screening? Screening is a process of identifying apparently healthy people who may be at increased risk of a disease or condition. They can then be offered

0 downloads 3 Views 1,68 MB Size Report
  1. Screening Dr Helen Raison Consultant, Public Health Royal Borough of Kingston

  2. What is screening? Screening is a process of identifying apparently healthy people who may be at increased risk of a disease or condition. They can then be offered information, further tests and appropriate treatment to reduce their risk and/or any complications arising from the disease or condition.

  3. UK Population Screening Programmes Antenatal and Newborn Young Person and Adult • sickle cell and thalassaemia • diabetic eye • fetal anomaly • abdominal aortic aneurysm • infectious diseases in • breast cancer pregnancy • cervical cancer • newborn and infant physical • bowel cancer examination • newborn blood spot • newborn hearing Have to meet strict criteria to be introduced as a managed screening programme by National Screening Committee

  4. Antenatal And Newborn Screening Programmes

  5. Adult Screening Programmes

  6. Adult Screening Programmes

  7. Diabetic Retinopathy Screening Programme • Diabetes can lead to diabetic eye disease. • Early identification and treatment of diabetic eye disease can reduce sight loss. • The main treatment for diabetic retinopathy is laser surgery. • All people with known type 1 and type 2 diabetes aged 12 or over are invited for screening • People already under the care of an ophthalmology specialist for the condition are not invited for screening. • The programme offers pregnant women with type 1 or type 2 diabetes additional tests because of the risk of developing retinopathy • 79.4% of those offered a test attended and had digital screening

  8. Abdominal Aortic Aneurysm Screening Programme • programme-overview

  9. Breast Cancer Screening Programme • Women age 50-70 automatically invited every 3 years • Some older and younger women are invited as part of a screening study • Women over 70 can continue to have breast screening every 3 years but have to request it • Finds small cancers which cannot yet be seen or felt • Main risk is that some women will be diagnosed and treated for a breast cancer that would never otherwise have been found or caused them harm • 66.2% eligible women screened in last 3 years in South West London. Lower than target of 70% coverage • Screening leaflets breast-screening-information-leaflets.

  10. Bowel Cancer Screening Programme • Offered every 2 years to all men and women aged 60 to 74 • Information letter sent, followed by posted faecal occult blood sampling kit. The kit includes simple instructions for taking sample at home and sending to lab • The sample is then processed and the results sent to the individual within 2 weeks. • Colonoscopy for those with abnormal screening result (to look at bowel lining) • 53.9% eligible people been screened in past 2.5 years in SWL. Working to increase this. • A bowel scope screening programme is being introduced for all men and women in England aged 55

  11. Cervical Cancer Screening Programme • overview

  12. Why some screening tests are not run as screening programmes? • National Screening Committee makes recommendations on 109 conditions • Reviews every 3 years • Uses evidence to decide if population screening should be introduced, changed or stopped • Examples of conditions where NSC has recommended ‘no’ in 2017 include: • Asymptomatic bacteriuria • Antenatal carriage of Group B streptococcus • Ovarian Cancer • Duchenne Muscular Dystrophy

  13. Prostate Cancer – PSA screening test • Second leading cause of cancer-related death in UK men • Risk of prostate cancer increases with age, family history, in black men, in overweight and obese men • NSC does not recommend universal screening (2016) • Slow growing prostate cancer is common, may not cause symptoms or shorten life • Abnormal PSA test may mean a man has cancer, but it may mean he does not (3 in 4 men wont) • PSA test cannot distinguish fast-growing from slow-growing cancers • Prostate cancer screening can reduce prostate cancer deaths by 21% but it can also lead to major harms caused by treating men who incorrectly testing positive. NSC concluded that harms outweigh the benefits. • Work is ongoing to increase the accuracy of the PSA test • Information on PSA test: problems/prostate-specific-antigen-test-psa • NHS/PHE Prostate Cancer Risk Management Programme – guidance for GPs and patients to decide whether to do a PSA test

  14. Who is who in screening ? UK National Screening Committee advises ministers and the NHS in the 4 UK countries about all aspects of screening and supports implementation of screening programmes PHE Screening and NHSE England PHE lead the national population screening programmes, and advise NHSE NHS, GPs, Hospitals Royal Borough Kingston Public Screening Commissioners who deliver the screening programmes Health Team assures local commission the programmes at screening centres, maternity programmes, holds PHE/NHSE units, GP surgeries, local clinics to account, supports work to reduce inequalities in access to screening Helen Raison, Screening Assurance Lead

Recommend Documents

1 2 3 4 5
1 2 3 4 5 F I N A N C I A L P R O


diabetic eye screening what is diabetic eye screening

DIABETIC EYE SCREENING What is Diabetic Eye Screening? Diabetic eye

Goals CRC/Screening Facts Available

9/13/2019 Goals CRC/Screening Facts Available CRC Screening Tests Tools To

diabetic eye screening extended screening intervals
Diabetic Eye Screening Extended

Diabetic Eye Screening Extended Screening Intervals Public Health England

colorectal cancer screening
Colorectal Cancer Screening Fall 2018

Colorectal Cancer Screening Fall 2018 Agenda CRC Screening Landscape

Roadmap Complexities of screening

6/23/2016 Roadmap Complexities of screening Illustrative example: breast

metal screening screening metal
Metal - - screening screening Metal

Metal - - screening screening Metal Thomas-Fermi (static) screening

chemspace virtual screening set description
Chemspace Virtual Screening Set

Chemspace Virtual Screening Set Description Virtual screening (VS) has been

apd screening status
APD screening status

APD screening status Andrea Wilms GSI Darmstadt PANDA

what parents and caregivers should know what is newborn
What Parents And Caregivers Should Know

What Parents And Caregivers Should Know What is Newborn Screening? Who

peripheral mycotic aneurysm with enterococcus faecalis
Peripheral mycotic aneurysm with

Peripheral mycotic aneurysm with Enterococcus faecalis bacteremia: A rare case

ati neurovascular cast system
ATI Neurovascular Cast System Naser

ATI Neurovascular Cast System Naser Alosaimi Jalando Edison Justin McCallin

complex percutaneous coronary intervention for acute


late presentation of fibromuscular dysplasia in an
Late Presentation of Fibromuscular

Proceedings of UCLA Healthcare -VOLUME 21 (2017)- CASE REPORT Late

vascular ultrasound
Vascular Ultrasound Kim Kargaard

Vascular Ultrasound Kim Kargaard Bredahl, MD, Ph.D Background Resident in

sensitivity analysis of simulated blood flow in cerebral
Sensitivity Analysis of Simulated Blood

Background And Motivation Numerical Methods Qualitative Analysis

oral case presentation guidelines for 3 rd year medicine
Oral Case Presentation Guidelines for 3

Oral Case Presentation Guidelines for 3 rd year Medicine Clerkship Steve

maternal mortality and severe morbidity in arizona
Maternal Mortality and Severe

Maternal Mortality and Severe Morbidity in Arizona Attached to every

Headaches Dr. Elliott Bogusz

Headaches Dr. Elliott Bogusz Neurology FRCPC, CSCN (EMG) Outline Red Flags

disclosure statement of financial interest
Disclosure Statement of Financial

The Final Results with Primary End Point Analyses RANDOMIZED EVALUATION OF

VASCern The European Network on Rare

VASCern The European Network on Rare Multisystemic Vascular Diseases MEMBERS

terms to know
Terms to know Ischemia Infarction

Terms to know Ischemia Infarction Atherosclerosis Thromboembolism